Endocare auditors retract backing for finance reports
This article was originally published in Clinica
Executive Summary
KPMG, the auditor for Irvine, California-based urological diagnosis and device specialist Endocare, has withdrawn the company's financial reports for the past year and a half saying that it cannot rely on "the representations of senior management". As a result, Nasdaq has halted trading in the company's shares.